Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.
Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.
Watch an expert in thrombosis and haemostasis address reversal strategies in patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH).
Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.
Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.
Watch an expert in thrombosis and haemostasis address reversal strategies in patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH).
Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.
Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
Watch three experts provide insights on the impact of ICH in patients receiving DOACs, DOAC-ICH reversal agents and optimizing treatment outcomes.
Watch three experts share their perspectives and best-practice guidance on how to optimize the diagnosis and management of pulmonary arterial hypertension (PAH).
Watch experts in endocrinology and in primary care discuss key considerations for addressing cardiorenal outcomes in patients with CKD/T2D
Watch a multidisciplinary team and a patient discuss new and emerging therapies for HFrEF and their incorporation into daily practice.
Select a discussion in the hub to watch our multidisciplinary faculty share their insights on how novel lipoprotein-lowering therapies can help to reduce ASCVD risk and what this may mean for patient care in the future.
touchCARDIOLOGY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events
Watch a panel of experts discuss strategies to support patients following a diagnosis of heart failure with reduced ejection fraction (HFrEF), implementing evidence-based therapies into clinical practice and the role of biomarkers in patient management.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.